Taipei, Taiwan

Yen-Chu Lin

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Insilico Medicine IP Limited. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yen-Chu Lin. Retrieved from https://idiyas.com/inventor/yen-chu-lin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yen-Chu Lin: Innovator in Molecular Generation

Introduction

Yen-Chu Lin is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of molecular generation, particularly through his innovative patent work. His expertise lies in developing methods that enhance the understanding and generation of molecular structures.

Latest Patents

Yen-Chu Lin holds a patent titled "Structure-based deep generative model for binding site descriptors extraction and de novo molecular generation." This patent describes a method of sampling a ligand, which includes receiving a target descriptor and generating a latent descriptor in an engineered chemical space. The process ultimately leads to the generation of a ligand descriptor based on the latent descriptor.

Career Highlights

Yen-Chu Lin is associated with Insilico Medicine IP Limited, where he applies his knowledge and skills to advance research in molecular generation. His work is pivotal in the development of new methodologies that can significantly impact drug discovery and design.

Collaborations

Yen-Chu Lin collaborates with talented individuals such as Ya-Chu Yang and Tzu-Lan Yeh. These partnerships enhance the innovative potential of their projects and contribute to the advancement of their research goals.

Conclusion

Yen-Chu Lin is a key figure in the field of molecular generation, with a focus on innovative methods that facilitate drug discovery. His contributions through patents and collaborations continue to shape the future of molecular research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…